U
Acura Pharmaceuticals, Inc. ACUR
OTC PK
Recommendation
--
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2021 06/30/2021 03/31/2021 12/31/2020 09/30/2020
Net Income -262.00K -387.00K -259.00K -243.00K -678.00K
Total Depreciation and Amortization 27.00K 18.00K 18.00K 19.00K 20.00K
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 15.00K 29.00K -- -214.00K 9.00K
Change in Net Operating Assets 411.00K 146.00K -72.00K 358.00K 104.00K
Cash from Operations 191.00K -194.00K -313.00K -80.00K -545.00K
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued 0.00 0.00 266.00K 0.00 0.00
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 0.00 0.00 3.00K 0.00 0.00
Repurchase of Common Stock 0.00 0.00 -8.00K 0.00 0.00
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -269.00K -- -- -- --
Cash from Financing -269.00K 0.00 261.00K 0.00 0.00
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -78.00K -194.00K -52.00K -80.00K -545.00K
Weiss Ratings